| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.47 | 0.005 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.008 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |